We’re pleased to welcome Imperial College Healthcare NHS Trust to the MND SMART team. The addition of this new trial site means that people living with Motor Neuron Disease can now take part in MND SMART at 25 locations across the UK.
Dr Radu Stoica, Sub-Investigator says:
We are delighted to offer our patients the opportunity to participate in the MND SMART trial. For the first time, patients living with MND in West London will be able to join a major therapeutic clinical trial without having to travel to other Centres. This is an important milestone for our service
MND SMART is currently testing 2 repurposed drugs; Amantadine and Tacrolimus. Read more about these drugs here https://mnd-smart.org/about/trial-drugs
If you are interested in participating in MND SMART in Imperial College Healthcare NHS Trust, please register your interest here https://mnd-smart.org/contact/register-interest
For a full list of trial centres please visit https://mnd-smart.org/about/trial-centres
If you are an investigator that is interested in opening an MND SMART trial centre locally, please get in touch
MND SMART is led by the Euan MacDonald Centre for MND Research at the University of Edinburgh. The trial is a flagship project of the UK Dementia Research Institute.
The trial is funded by the Euan MacDonald Centre for MND Research, MND Scotland, MND Association, the Alan Davidson Foundation, My Name’5 Doddie Foundation and Baillie Gifford.